Patent · US Active

Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome

US8501473B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignee

EVOTEC INTERNATIONAL GmbH · DE

Inventors

Daria Onichtchouk · Oettingen, DE
Ulrike Burk · Oebisfelde, DE

Key dates

Filing date	Jul 15, 2004
Grant date	Aug 6, 2013
Priority date	—
Expiry date	Oct 31, 2028

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention discloses the protein pleiotrophin secreted by the developing pancreas, and polynucleotides, which identify and encode this protein. The invention also relates to the use of these sequences in the diagnosis, study, prevention, and treatment of pancreatic diseases (e.g. diabetes), obesity, and/or metabolic syndrome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.